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 Introduction 
 Frontotemporal dementia (FTD) is a neurodegenera-
tive disorder predominantly affecting the frontal and 
temporal lobes, presenting with prominent behavioural 
and personality changes, followed by disturbances of ex-
ecutive functions, language and memory. Although often 
under-recognised, FTD accounts for about 13% of de-
mentia cases and for 12–22% of dementia incidences 
starting before the age of 65 years  [1, 2] . In 1994 the Lund 
and Manchester international consensus meeting drew 
the attention towards the syndrome in a mainly descrip-
tive way  [3] . A few years later, the Lund and Manchester 
criteria were refined to the concept of frontotemporal lo-
bar degeneration (FTLD), representing a clinical spec-
trum of the prototypical variants FTD, semantic demen-
tia and progressive non-fluent aphasia  [4] . For FTD a set 
of 5 core criteria was formulated together with a number 
of supportive features and exclusion criteria. In the most 
recent consensus conference, FTLD was simply divided 
into the behavioural and the language variants of FTD, 
whereas the main focus lies on pathological classification 
 [5] . To date, the most broadly applied in clinical practice 
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 Abstract 
 Background/Aims: The goal of the present study was to 
evaluate the diagnostic accuracy of the core diagnostic cri-
teria for frontotemporal dementia (FTD) [Neary D, et al: Neu-
rology 1998; 51: 1546–1554] within a memory clinic popula-
tion.  Methods: The 5 core diagnostic criteria for FTD were 
operationalised in an informant-based written question-
naire. For a diagnosis of FTD the total clinical picture was 
weighted with findings on additional investigations and 
possible exclusion criteria, with follow-up of at least 1 year. 
 Results: The operationalised core criteria for FTD had a sen-
sitivity of 79% (95% CI = 57–92) and a specificity of 90% (95% 
CI = 85–94).  Conclusion: The core diagnostic criteria for FTD 
applied in a caregiver questionnaire have good diagnostic 
accuracy among subjects without advanced dementia at-
tending a memory clinic. This stresses the importance of the 
informant-based history in the differential diagnosis of de-
mentia.  Copyright © 2008 S. Karger AG, Basel 
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are the Neary and Snowden diagnostic criteria  [4] . In 
clinical practice, the use of these criteria raises several 
questions. Their reliability has only scarcely been inves-
tigated and no prospective studies have been performed. 
The most recent study investigated ante-mortem clinical 
diagnoses in 34 patients with autopsy-proven FTLD in a 
memory clinic cohort and found a sensitivity of 85% and 
a specificity of 99% of the Neary and Snowden diagnostic 
criteria  [6] . In this study, diagnoses were based on the 
composite of the clinical syndrome, neuropsychological 
findings and neuroimaging results, evolving over time. A 
retrospective clinico-clinical study, however, found that 
the core clinical diagnostic criteria had a sensitivity of 
only 36.5% for FTD  [7] . Moreover, it is hard to qualify and 
quantify behavioural and emotional characteristics rep-
resented in the 5 core diagnostic criteria, all needed for a 
diagnosis of FTD. As it is allowed to make a diagnosis of 
FTD based on purely clinical criteria, however, correct 
application of these behavioural criteria is essential. Ob-
servation of the patient is 1 means to do so, however, for 
a full appraisal of behavioural and emotional changes, 
the caregiver history is indispensable. In the current 
study the presence or absence of the Neary and Snowden 
core diagnostic criteria for FTD was rated by caregivers 
using an informant-based questionnaire. The diagnostic 
accuracy of the operationalised clinical diagnostic crite-
ria was determined with reference to the multidisci-
plinary diagnosis confirmed by at least 1 year of follow-
up.
 Methods 
 Development and Application of a Questionnaire 
 A written caregiver questionnaire was developed in which the 
5 core diagnostic criteria were formulated as a question. For ex-
ample, ‘an early change in personal behaviour’ was formulated as: 
‘Has there been an evident change of his/her personal behaviour?’ 
The addition ‘early’ is not formulated in this question, as only 
subjects with no or mild dementia were included (see patient sec-
tion). On the other hand, to avoid a high number of positive an-
swers in all cases with slight personal behaviour change, the ad-
dition ‘evident’ was made. Subsequently, only in case of a positive 
answer to the questions on ‘behaviour towards other people’ 
(question No. 2) and ‘personal behaviour’ (question No. 3) a sec-
ond set of questions was presented to identify the type of behav-
iour or personality change. These were derived from various 
questionnaires and descriptions of characteristic behaviour in 
FTD in the literature  [3, 8–12] . The original Dutch version as well 
as a translation of the full questionnaire is illustrated in the ap-
pendix.
 The questionnaire was sent to caregivers or relatives of sub-
jects visiting the VU University Medical Centre (VUMC) memo-
ry clinic prior to their first consultation, as part of the standard 
screening procedure. They were strictly instructed to fill in the 
questionnaire independently of the patient. The completed ques-
tionnaires were stored apart from the medical notes of the pa-
tients during the inclusion period. The subjects were referred for 
memory and/or behavioural complaints by general practitioners 
and medical specialists (neurologists, psychiatrists and geriatri-
cians).
 Acquisition of Patients and Diagnostic Procedure 
 All subjects underwent a standard diagnostic procedure in-
cluding extensive and detailed medical and informant-based his-
tory, physical and neurological examination, screening labora-
tory tests, psychometric testing, EEG and MRI. Disease duration 
was calculated as the time difference between reported symptoms 
and time of presentation. Laboratory tests consisted of ESR, com-
plete blood count, serum electrolytes, glucose, blood urea nitro-
gen/creatinine, liver enzymes, folate, vitamins B1, B6 and B12 and 
thyroid function. Psychometric testing included elements of the 
Wechsler Adult Intelligence Scale, 3rd Edition, Visual Associa-
tion Test  [13] , 15 Word Recall, Digit Span, Trail Making Tests, 
Category Fluency, Stroop Colour Word Interference Test, ele-
ments of the Behavioural Assessment of the Dysexecutive Syn-
drome  [14] and Rey-Osterrieth Complex Figure Test. Clinical De-
mentia Rating was assessed in all subjects  [15] . In most cases the 
Mini-Mental State Examination (MMSE) was performed  [16] . On 
indication, the patients underwent a second set of investigations, 
such as sleep registration.  99m Tc-hexamethyl propyleneamine ox-
ide (HMPAO) SPECT or  18 F-fluorodeoxyglucose PET were per-
formed in case of suspected dementia but normal structural im-
aging or to differentiate between types of dementia, mostly FTD 
and Alzheimer’s disease (AD). Diagnoses were made in a multi-
disciplinary team consisting of neurologists, a psychiatrist, a ger-
iatrician, a clinical neurophysiologist, a radiologist and a neuro-
psychologist, who were blind to the questionnaire answers. De-
tailed history taking, cognitive examination and behavioural 
observation were part of the routine screening procedure. Diag-
noses were based on the respective international diagnostic crite-
ria  [17–20] . The clinical diagnosis of FTD was based on personal-
ity and behavioural change resulting in social dysfunctioning, 
emotional blunting and lack of insight, taking into account the 
supportive and exclusion criteria of Neary and Snowden  [4] . Sta-
bility of the multidisciplinary diagnosis of FTD after 1 year of 
clinical follow-up was used as the gold standard. All other diag-
noses were kept under review and discussed in the multidisci-
plinary team after 1 year as well.
 To increase the sample size, an additional 23 FTD patients who 
had undergone the same diagnostic procedure were recruited 
from memory clinics of the Hagaziekenhuis in The Hague (J.
L.M.) and the Erasmus Medical Centre in Rotterdam (J.C.v.S.).
 Data Analysis 
 In the period August 2002 to January 2005 from a total of 603 
subjects 441 questionnaires were returned. One of the reasons for 
not returning the questionnaire was the lack of any reliable infor-
mant. Eighty-seven questionnaires were excluded for incorrect 
completion. These concerned questionnaires with  ! 5 core ques-
tions filled in, or without specification of the behavioural and 
personal items in case of a positive answer to the screening ques-
tions.
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 Because the diagnosis of FTD is most relevant and most dif-
ficult in the early stages of dementia, subjects with moderate to 
advanced dementia (Clinical Dementia Rating  1 1, n = 36) were 
excluded from analysis. Moreover, subjects with an obvious ex-
planation for cognitive decline at first presentation, other than 
neurodegenerative causes, were excluded. General examination 
revealed severe bradycardia with cerebral hypoperfusion (n = 1), 
severe alcohol abuse (n = 2) and delirium (n = 2). MRI identified 
extensive vascular involvement or strategic infarcts (n = 16), post-
traumatic abnormalities (n = 3) and normal pressure hydroceph-
alus (n = 2). Temporal epilepsy was identified by EEG (n = 7). In 
all cases clinical follow-up confirmed that the clinical picture of 
cognitive deterioration could not otherwise be explained.
 Eighty-eight patients were excluded because the clinical fol-
low-up had been  ! 1 year. Four patients had an initial diagnosis of 
FTD, AD or a psychiatric disorder that proved to be incorrect at 
follow-up. Because the follow-up of the second diagnosis was 
shorter than 1 year, these subjects were excluded as well.
 In the included cohort we calculated sensitivity, specificity, 
positive predictive value, negative predictive value and likelihood 
ratios for the presence of 5 positive criteria (positive test) as op-
posed to  ! 5 positive criteria (negative test) including 95% confi-
dence intervals (CI). Where TN is true negative, TP is true posi-
tive, FN is false negative, and FP is false positive, specificity was 
defined as TN/(TN + FP), sensitivity as TP/(TP + FN), positive 
predictive value as TP/(TP + FP) and negative predictive value as 
TN/(TN + FN). The likelihood ratio for a positive test result was 
defined as sensitivity/(1 – specificity) and the likelihood ratio for 
a negative test result as (1 – sensitivity)/specificity. Using CIA 
software (version 2.1.1), 95% CI were calculated.
 After the addition of 23 FTD cases from other memory clinics 
the diagnostic odds ratio of the 5 core criteria was calculated as 
the ratio between TP  ! TN and FP  ! FN. Lastly, answers to the 
20 behavioural and personality items were evaluated within the 
VUMC memory clinic population.
 Results 
 A total of 193 subjects were included in the analysis. 
Demographic and clinical characteristics of the main di-
agnostic groups are displayed in  table 1 . Nineteen pa-
tients with a diagnosis of FTD were identified. Seventy 
patients had been diagnosed as having AD. Other demen-
tias than FTD and AD included semantic dementia (n = 
5) and progressive non-fluent aphasia (n = 2), dementia 
with Lewy bodies (n = 6), corticobasal degeneration (n = 
3) and Parkinson’s disease dementia (n = 2). Note that al-
though the patients were at most mildly demented, MMSE 
scores in the lower range occurred in cases with severe 
language disturbances. Thirty-seven subjects had subjec-
tive complaints without cognitive impairment, and 30 
subjects had mild cognitive impairment  [19] . Other dis-
orders included obstructive sleep apnoea syndrome in 1 
patient and a self-limiting frontal lobe syndrome proba-
Table 1. Demographic and clinical characteristics of the main diagnostic groups
Group FTD
(n = 19)
AD
(n = 70)
Other
dementias
(n = 18)
MCI
(n = 30)
Subjective
complaints
(n = 37)
Other 
disorders
(n = 19)
Sex (male:female) 14:5 34:36 12:6 17:13 18:19 10:9
Age, years 58 (47–83) 69 (52–83) 68 (51–82) 69 (60–79) 61 (52–87) 65 (45–79)
Disease duration, years 5 (2–8) 3 (1–10) 2 (1–10) 3 (0.5–6) 3 (1–10) 3 (1–5)
Follow-up duration, months 14 (12–44) 24 (12–43) 24 (12–36) 23 (12–40) 16 (12–43) 15 (12–34)
CDR 1 (0.5–1) 1 (0.5–1) 1 (0.5–1) 0.5 (0.5) 0 (0–0.5) 0.5 (0–1)
MMSE 27 (19–30) 23 (7–29) 23 (15–28) 28 (21–30) 29 (25–30) 28 (19–30)
Values are displayed as medians (range). MCI = Mild cognitive impairment; disease duration = reported duration of symptoms till 
time of diagnosis; follow-up duration = duration of clinical follow-up since time of diagnosis; CDR = Clinical Dementia Rating.
Table 2. Sensitivity, specificity, positive and negative predictive 
values and positive and negative likelihood ratios calculated for 
the presence of 5 positive answers on the core item caregiver ques-
tionnaire (n = 193)
Measure Point estimate 95% CI
Sensitivity, % 79 57–92
Specificity, % 90 85–94
PPV, % 47 31–64
NPV, % 98 94–99
LR+ 8.1 4.9–13.4
LR– 0.2 0.1–0.6
PPV = Positive predictive value; NPV = negative predictive 
value; LR+ = positive likelihood ratio; LR– = negative likelihood 
ratio.
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Table 3. Clinical and demographic data of FTD patients
Case Sex Age
years
Disease
duration
years
Presenting features MMSE An-
swers
Remarks
VUMC1 m 55 6 hoarding, decreased self-care 19 4
VUMC2 f 64 3 language disturbances 28 4
VUMC3 m 58 5 disinhibition, emotional unconcern 26 5
VUMC4 m 57 6 childish behaviour Np 5
VUMC5 m 54 4 prosopagnosia, restlessness Np 4
VUMC6 m 56 4 apathy, ritualistic behaviour 27 5 bipolar disorder in history
VUMC7 m 83 5 irritability, paranoid behaviour 29 5
VUMC8 m 52 2 withdrawal, stereotyped behaviour NP 5
VUMC9 m 47 5 language disturbances, decreased planning,
emotional lability
NP 5
VUMC10 f 58 8 language disturbances, socially inadequate
behaviour
27 5
VUMC11 f 65 3 apathy, irritability NP 5
VUMC12 m 57 5 decrease of practical skills, self-centredness 28 5
VUMC13 m 73 2 self-centredness, impulsiveness, aggression 23 5
VUMC14 m 54 5 apathy, gluttony 30 5
VUMC15 f 63 3 compulsiveness, emotional lability 23 5
VUMC16 m 53 4 language disturbances NP 4
VUMC17 m 67 3 alcohol abuse, stereotyped behaviour 25 5 post-mortem: tau–, ubiquitin+
VUMC18 f 60 6 loss of initiative, claiming behaviour 24 5
VUMC19 m 59 6 obsessive-compulsive behaviour 27 4
HZ1 m 55 8 loss of initiative, stereotyped behaviour 28 4
HZ2 m 70 5 severe apathy 29 5
HZ3 m 84 5 aggression, claiming behaviour NP 5
HZ4 m 62 1 emotional unconcern, apathy NP 4
HZ5 m 54 2 sexual disinhibition, stereotyped behaviour 30 3 post-mortem: neuronal loss, 
gliosis, tau–, ubiquitin–
HZ6 m 70 2 withdrawal, irritability 28 5
HZ7 f 86 4 emotional flattening, perseveration 28 5
HZ8 m 73 2 emotional unconcern, apathy 27 5
HZ9 m 51 2 emotional unconcern, socially inappropriate behaviour 26 5
HZ10 m 52 1 disorganisation, aggression 30 5
HZ11 f 78 7 aggression, disinhibition NP 5
HZ12 f 72 1 language disturbances 29 3
EMC1 m 58 2 concentration problems, language disturbances NP 4
EMC2 m 72 5 language disturbances 30 4
EMC3 f 52 3 aggression, language disturbances 13 5
EMC4 m 52 3 apathy, language disturbances 20 5 P301 MAPT mutation
EMC5 m 51 4 language disturbances, emotional unconcern 29 5
EMC6 f 66 6 prosopagnosia, language disturbances NP 5
EMC7 m 68 7 socially inadequate behaviour, aggressive 29 5
EMC8 m 57 8 disinhibition, language disturbances NP 5
EMC9 m 78 5 disinhibition, language disturbances 19 4
EMC10 m 40 10 emotional unconcern, aggression 23 4
EMC11 m 72 4 stereotyped behaviour, inhibition 26 5
NP = Not performed; answers = number of positive answers on caregiver questionnaire; MAPT = microtubule-associated protein tau.
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bly related to cerebrovascular disease in another patient. 
Nine subjects mostly had symptoms of depression, anxi-
ety or personality disorder. In 8 subjects the eventual di-
agnosis had been postponed. Post-mortem pathological 
confirmation was achieved in 1 patient with a clinical di-
agnosis of probable AD and in 1 patient with FTD.
 In  table 2 measures of diagnostic accuracy are dis-
played. The presence of 5 core diagnostic criteria accord-
ing to the caregiver questionnaire had a sensitivity of 79% 
(95% CI = 57–92) and a specificity of 90% (95% CI = 85–
94) for a clinical diagnosis of FTD.
 The 4 FTD patients who did not fulfil all 5 core criteria 
scored a total of 4 positive answers on the questionnaire. 
Thus, if a cut-off score of 4 positive core items had been 
applied, the sensitivity would have risen to 100%, how-
ever, at the cost of the specificity, which would have 
dropped to 66% (95% CI = 59–73). A score  ! 5 on the care-
giver questionnaire had a negative predictive value of 
98% (95% CI = 94–99), meaning that a diagnosis of FTD 
was almost excluded.
 Seventeen subjects with other diagnoses than FTD 
had a score of 5 core diagnostic criteria. These included 8 
out of 70 patients with probable AD, 3 out of 6 patients 
with probable dementia with Lewy bodies, 3 individuals 
with subjective complaints and 2 persons in whom no 
definite diagnosis could be made. In 1 individual with 
subjective complaints and in 1 with a postponed diagno-
sis, a diagnosis of FTD was suspected.
 Of the 19 subjects diagnosed as having FTD, 10 had 
abnormal structural imaging consistent with FTD, 6 had 
a frontal/temporal deficit on functional imaging ( 18 F-flu-
orodeoxyglucose PET or HMPAO SPECT) and 17 had 
psychometric testing suggestive of FTD. In all cases at 
least 1 of these ancillary investigations was abnormal. In 
1 patient the diagnosis of FTD was confirmed by post-
mortem neuropathological examination revealing spon-
giosis and gliosis of the temporal cortices, hippocampi 
and amygdalae with tau-negative, ubiquitin-positive in-
clusions.
 The FTD sample was then enriched with 23 patients 
from 2 other memory clinics with questionable to mild 
dementia, all of whom had had follow-up of at least 1 year. 
Clinical and demographic data of the total group of FTD 
patients are presented in  table 3 . The diagnostic odds ra-
tio of the 5 core criteria was 23 (95% CI = 10–53). The 
sensitivity of the 5 core criteria decreased to 71% (95%
CI = 56–83).
 Measures of diagnostic accuracy were calculated for 
the individual behavioural items for FTD (second page of 
the questionnaire). High specificities were found for im-
pulsiveness (88%), change of food preferences (82%), 
change of hobbies (97%) and self-centredness (83%), how-
ever, with relatively low sensitivities (41, 35, 16 and 78% 
respectively). The items with the highest sensitivity were 
a reduction in spontaneous speech (less talkative, sensi-
tivity = 94%), a change of emotional reactions (94%) and 
reduced planning (100%), all at low specificity (30, 39 and 
12% respectively).
 Discussion 
 This study examined the diagnostic accuracy of the 
core clinical diagnostic criteria for FTD operationalised in 
an informant-based questionnaire. The 5 core diagnostic 
features rated by caregivers had a good diagnostic accu-
racy to identify FTD among subjects presenting at a mem-
ory clinic who were at most mildly demented. The high 
diagnostic accuracy was maintained when combining data 
from our own patient cohort with those of 2 other memo-
ry clinics. Individual questions addressing different as-
pects of behaviour and personality were of less diagnostic 
value. Only a change of hobbies and interests yielded a 
specificity higher than the 90% specificity of the 5 core 
items. Moreover, impulsiveness, change of food preference 
and self-centredness were specific features for FTD (spec-
ificity  1 80%), at the cost of a relatively low sensitivity. Re-
markably, some conducts that appear to be characteristic 
of FTD, such as stereotyped behaviour and perseveration, 
had a low specificity for FTD in our study  [21, 22] .
 Although in our memory clinic population the core 
diagnostic criteria yielded a sensitivity of 79% and speci-
ficity of 90%, we checked whether the good diagnostic 
accuracy was maintained by enriching our FTD sample. 
For this, we used the diagnostic odds ratio that is often 
used as a measure of the discriminative power of a test. A 
value of 1 means that the test discriminates at chance 
level. Very high values  1 1 mean that a test discriminates 
well. In our study the presence of 5 core items increases 
the odds of having FTD with a factor 23.
 One of the strengths of this study is the prospective 
design with a relatively large number of subjects. Con-
trary to previous studies examining the diagnostic valid-
ity of clinical criteria by rating patient features using chart 
review  [6, 7, 23] , the presence or absence of the core diag-
nostic criteria in our study was rated by the patients’ care-
givers. As behavioural and emotional changes that char-
acterise the frontal lobe syndrome are highly environ-
ment dependent and might not directly come out in the 
structured setting of a memory clinic, caregivers who live 
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with the patients can be considered the experts for assess-
ing behavioural abnormality. The approach of a written 
questionnaire was chosen with the intention to obtain 
caregiver information at the highest possible reliability. 
The aim of the questionnaire, other than to collect behav-
ioural information, was not disclosed to the caregivers. 
They were instructed to fill in the questionnaire indepen-
dently of the patients. Moreover, their ratings were not 
influenced by the interpretation of the clinicians. Al-
though we considered it an advantage for objectivity to 
use written questionnaires, it is remarkable that a rela-
tively high number of subjects filled in the questionnaire 
incompletely or incorrectly. Because it was not our goal to 
develop a behavioural questionnaire, but to examine the 
presence or absence of the core diagnostic criteria of
Neary and Snowden according to the caregiver by liter-
ally putting a question mark behind each criterion, we did 
not examine the face validity of the questions. It might be 
well possible that terms such as ‘change of personal behav-
iour’ were too abstract for caregivers or relatives.
 Another strength is that we investigated a group of 
subjects with no, questionable or mild dementia, as clin-
ical diagnosis is of most relevance in an early stage for 
prognostic and therapeutic reasons. The reproducibility 
of our findings was assessed by examining a proportion 
of subjects from 2 other memory clinics. Thus, our find-
ings yield a relatively high diagnostic accuracy for FTD 
in an early to moderate stage, just by collecting written 
caregiver information. The sensitivity of the clinical di-
agnostic criteria in our cohort is higher than that found 
in a clinico-clinical study using chart review as a method 
to assess the presence or absence of the core criteria  [7] . 
On the other hand, the fact that the clinical picture be-
comes clearer during the course of the disease might ex-
plain why sensitivities  1 79% were found in 2 other stud-
ies  [6, 23] . To test this hypothesis, longer clinical follow-
up of our cohort is needed, in particular of the 2 subjects 
with a positive questionnaire and a suspicion of FTD. In 
this respect, adding a degree of certainty to the existing 
diagnostic criteria, like it is applied in the criteria for oth-
er types of dementia  [17, 18, 20] , would increase the aware-
ness of cases with ‘possible FTD’ and encourage long-
term clinical follow-up.
 Although there are several explanations why our anal-
ysis could be performed in a relatively small proportion 
of the original number of 603, it cannot be excluded that 
our results were biased by the fact that caregivers of sub-
jects with the most pronounced behavioural changes 
were more likely to respond than those whose partners 
had no remarkable behaviours.
 Our results can only be considered in the context of a 
memory clinic setting. Misdiagnosis of FTD in the early 
stages is common  [24, 25] . Because of the relatively young 
age of onset and the predominance of behavioural fea-
tures, these patients are often referred for psychiatric 
evaluation  [26] . FTD patients with the most prominent 
behaviour disturbances might therefore be referred to 
psychiatrists, whereas those with relatively more cogni-
tive complaints are referred to a memory clinic. This se-
lection bias could have particularly influenced the sensi-
tivity of the diagnostic criteria in our study. On the other 
hand, it is conceivable that the specificity of the diagnos-
tic criteria is much lower if the reference population con-
sists of patients with psychiatric disorders.
 We are aware that our study is hampered by inevitable 
circular evidence because the caregiver answers are not 
completely independent of the eventual clinical diagno-
sis. To escape full-circle reasoning, only the core criteria 
were evaluated using a written, informant-based ques-
tionnaire, prior to consultation. The additional personal 
and behavioural items served as a further specification as 
well as concrete examples. The clinical diagnosis of FTD, 
however, was based on clinician’s judgements that weighed 
the contributions of a thorough behavioural and cogni-
tive history and examination, supportive features includ-
ing predominant frontal/temporal atrophy on MRI and 
executive dysfunction on neuropsychological examina-
tion, whereas subjects with features such as spatial disori-
entation were excluded. Moreover, the clinical diagnosis 
had to remain consistent over time, implicitly suggesting 
clinical progression. The results of this study therefore 
depend both on the reliability of the caregiver answers as 
well as clinical judgement.
 Another weakness of our study is that pathological 
confirmation of the clinical diagnosis is lacking in the 
majority of cases. We excluded clear causes of cognitive 
disturbances, other than neurodegenerative dementia, 
because these could be identified at first evaluation and 
did not belong to the differential diagnosis of FTD. In the 
remaining subjects, long-term clinical follow-up was 
used as the gold standard and pathological confirmation 
was achieved in a small number of patients. As a tertiary 
referral centre using a multidisciplinary approach, we 
can rely on high diagnostic accuracy  [27] , but incorrect 
diagnosis in a proportion of patients cannot be fully ex-
cluded.
 As the core clinical characteristics are central in the 
diagnostic criteria of FTD, the role of additional investi-
gations remains to be investigated. The sensitivity of MRI 
has been reported to be between 50 and 64%  [6, 7] . Our 
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findings seem to be in line with a relatively low sensitiv-
ity of structural neuroimaging for FTD, as only 53% had 
an abnormal MRI at presentation. The sensitivity of 
SPECT/PET scans is much higher, around 90%  [7] . De-
spite prominent behavioural change, however, both MRI, 
HMPAO SPECT and psychometric testing may be nor-
mal in the early stages of FTD  [28] . Thus, behavioural 
changes may precede abnormal investigations. This could 
be another argument to add a degree of certainty (‘pos-
sible’, ‘probable’, ‘definite’) to the existing clinical diag-
nostic criteria. The diagnostic accuracy of the criteria is 
expected to be lower in less selected and less specialised 
settings. Therefore, a need for biomarkers capable of 
identifying FTD remains. Ideally these could serve as an 
aid to predict pathological phenotypes as well  [29] .
 In conclusion the core diagnostic criteria of Neary and 
Snowden, applied in an informant-based questionnaire, 
appear to be an appropriate tool for the early diagnosis of 
FTD in a memory clinic. These findings stress that care-
giver information plays an important role in the diagno-
sis of FTD. The challenge remains to evaluate the diag-
nostic accuracy for FTD within a psychiatric setting.
The subjects were asked to have the questionnaire filled in by a person who 
knew them well, for example their spouse, a relative or a good friend. The 
relatives or caregivers were instructed to fill in the questionnaire according 
to their personal view. It was requested to note the relationship of the rater 
towards the rated individual.
1 Has there been a gradual onset and gradual progression? Yes No
2 Has there been an evident change in his/her behaviour 
towards other people?
If yes, please answer the questions on the next page.
Yes No
3 Has there been an evident change in his/her personal
behaviour?
If yes, please answer the questions on the next page.
Yes No
4 Does he/she show lack of emotional concern? Yes No
5 Are complaints about his/her condition absent or
does he/she deny these?
Yes No
If you answered yes to question number 2, 
please answer the following questions.
1 Does he/she make inappropriate remarks or jokes? Yes No
2 Has he/she become argumentative? Yes No
3 Has he/she become socially withdrawn? Yes No
4 Has he/she become less talkative? Yes No
5 Other:
If you answered yes to question number 3,
please answer the following questions.
1 Has he/she become restless and/or overactive? Yes No
2 Does he/she show less initiative? Yes No
3 Has he/she become more impulsive? Yes No
4 Has he/she become rigid in habits? Yes No
5 Has grooming decreased? Yes No
6 Does he/she continue with certain actions for too long? Yes No
7 Does he/she repeat certain actions or remarks all the time? Yes No
8 Has he/she developed a different food preference? Yes No
9 Has there been a change in eating habits? Yes No
10 Has there been a change in hobbies and interests? Yes No
11 Does he/she wander or pace? Yes No
12 Has there been a change in his/her sexual behaviour? Yes No
13 Are his/her emotional reactions inappropriate or different 
from before? Yes No
14 Is he/she easily diverted? Yes No
15 Is his/her capacity to plan ahead/solve a problem reduced? Yes No
16 Has he/she become self-centred? Yes No
17 Other:
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